文献速递垂体与肾上腺疾病性腺与生殖内分泌

重新审视经典型3β-羟类固醇脱氢酶2缺乏症:来自31例儿科病例的启示

Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该多中心横断面研究纳入土耳其九家儿科内分泌诊所的31例临床诊断3βHSD2缺乏症患儿,分析其临床表现、基因型-表型-代谢组学关系。研究发现11种HSD3B2纯合突变(6种为新突变),体外活性>5%野生型的错义变异患者无失盐表型;所有遗传男性均有外生殖器模糊,女性仅1例阴蒂肥大;78%患者有阴毛早现。结论认为该病包括失盐与非失盐表型,女性外生殖器未男性化可能导致漏诊,LC-MS/MS测定的高基线17OHPreg与皮质醇比值及低11-氧雄激素可明确识别患者。

要点

  • 31例3βHSD2缺乏症患儿中检测到11种HSD3B2纯合突变,其中6种为新突变。
  • 体外3βHSD2活性>5%野生型的错义变异患者表现为非失盐型临床表型。
  • 所有遗传男性均有外生殖器模糊,而12例女性中仅1例外生殖器男性化。

核心结论

  • 基因确诊的3βHSD2缺乏症包括失盐型和非失盐型临床表型。
  • 女性保留的盐皮质激素功能及未男性化的外生殖器可能导致误诊和低估3βHSD2缺乏症的频率。
  • LC-MS/MS测定的高基线17OHPreg与皮质醇比值和低11-氧雄激素浓度可明确识别3βHSD2缺乏症患者。

研究设计与样本

  • 多中心、横断面研究,来自土耳其九家三级儿科内分泌诊所。
  • 纳入临床诊断3βHSD2缺乏症的儿童,使用结构化问卷评估临床数据。
  • 采用Sanger测序分析HSD3B2基因,新突变进行体外研究。
  • 使用LC-MS/MS测定19种血浆肾上腺类固醇。

主要发现

  • 在31例儿童(19例男性/12例女性;平均年龄6.6±5.1岁)中鉴定出11种HSD3B2纯合突变,其中6种为新突变。
  • 体外3βHSD2活性>5%野生型的HSD3B2纯合致病性错义变异患者具有非失盐型临床表型。
  • 外生殖器模糊是所有遗传男性的固定特征,而12例女性患者中仅1例表现为外生殖器男性化。
  • 78%的患者观察到阴毛早现。
  • 青春期女性出现月经不规则和多囊卵巢,男性出现肾上腺残余肿瘤和性腺功能衰竭。

关键数值与推荐

  • 体外3βHSD2活性>5%野生型的错义变异与无失盐表型相关。
  • 高基线17OHPreg与皮质醇比值和低11-氧雄激素浓度可明确识别3βHSD2缺乏症患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The clinical effects of classical 3β-hydroxysteroid dehydrogenase 2 (3βHSD2) deficiency are insufficiently defined due to a limited number of published cases. OBJECTIVE: To evaluate an integrated steroid metabolome and the short- and long-term clinical features of 3βHSD2 deficiency. DESIGN: Multicenter, cross-sectional study. SETTING: Nine tertiary pediatric endocrinology clinics across Turkey. PATIENTS: Children with clinical diagnosis of 3βHSD2 deficiency. MAIN OUTCOME MEASURES: Clinical manifestations, genotype-phenotype-metabolomic relations. A structured questionnaire was used to evaluate the data of patients with clinical 3βHSD2 deficiency. Genetic analysis of HSD3B2 was performed using Sanger sequencing. Novel HSD3B2 mutations were studied in vitro. Nineteen plasma adrenal steroids were measured using LC-MS/MS. RESULTS: Eleven homozygous HSD3B2 mutations (6 novel) were identified in 31 children (19 male/12 female; mean age: 6.6 ± 5.1 yrs). The patients with homozygous pathogenic HSD3B2 missense variants of > 5% of wild type 3βHSD2 activity in vitro had a non-salt-losing clinical phenotype. Ambiguous genitalia was an invariable feature of all genetic males, whereas only 1 of 12 female patients presented with virilized genitalia. Premature pubarche was observed in 78% of patients. In adolescence, menstrual irregularities and polycystic ovaries in females and adrenal rest tumors and gonadal failure in males were observed. CONCLUSIONS: Genetically-documented 3βHSD2 deficiency includes salt-losing and non-salt-losing clinical phenotypes. Spared mineralocorticoid function and unvirilized genitalia in females may lead to misdiagnosis and underestimation of the frequency of 3βHSD2 deficiency. High baseline 17OHPreg to cortisol ratio and low 11-oxyandrogen concentrations by LC-MS/MS unequivocally identifies patients with 3βHSD2 deficiency.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Guran T, Kara C, Yildiz M, et al. Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases. J Clin Endocrinol Metab. 2020. PMID: 31950145. doi:10.1210/clinem/dgaa022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。